Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Quadrivalent Influenza Virus Vaccine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01702454
What this trial is testing

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine When Administered in Children Who Previously Participated in Study 115345

Who this might be right for
Influenza
GlaxoSmithKline 470
Post-approval studies (Phase 4)Study completedNCT04109222
What this trial is testing

Collection of Serum Samples From Children and Older Adults Receiving the 2019-2020 Formulations of Fluzone® Quadrivalent and Fluzone® High-Dose Influenza Vaccines, Respectively

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 90
Large-scale testing (Phase 3)Study completedNCT03849560
What this trial is testing

Safety, Reactogenicity, Immunogenicity, Efficacy of Influenza Vaccines Grippol® Quadri and Grippol® Plus in Volunteers

Who this might be right for
Influenza
NPO Petrovax 612
Post-approval studies (Phase 4)Study completedNCT06020118
What this trial is testing

Comparative Immunogenicity of Concomitant vs Sequential mRNA COVID-19 and Influenza Vaccinations

Who this might be right for
InfluenzaCOVID-19
Duke University 455
Early research (Phase 1)Study completedNCT05252338
What this trial is testing

Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVSQIV in Healthy Adults

Who this might be right for
Influenza
CureVac 240
Testing effectiveness (Phase 2)Study completedNCT03336593
What this trial is testing

Protectivity and Safety of Quadrivalent Influenza HA Vaccine in Indonesian Population

Who this might be right for
Safety Issues
PT Bio Farma 810
Post-approval studies (Phase 4)Study completedNCT04559204
What this trial is testing

Evaluation of Safety and Immunogenicity of Combined Immunization of PPV23 and IIV4

Who this might be right for
Influenza, HumanPneumonia, Pneumococcal
China National Biotec Group Company Limited 1,224
Large-scale testing (Phase 3)Study completedNCT04101435
What this trial is testing

Immunogenicity and Safety Evaluation of QIS in Healthy Subjects

Who this might be right for
Influenza
Adimmune Corporation 174
Large-scale testing (Phase 3)UnknownNCT02806804
What this trial is testing

Safety and Immunogenicity Study of Quadrivalent Influenza Virus Vaccine in Healthy People Aged Years 3-60

Who this might be right for
Quadrivalent Influenza Virus Vaccine
Beijing Chaoyang District Centre for Disease Control and Prevention 2,400
Testing effectiveness (Phase 2)Study completedNCT02249221
What this trial is testing

Safety, Tolerability, and Immunogenicity of GC3106 (Quadrivalent Cell-culture Based Influenza Vaccine)

Who this might be right for
Influenza
Green Cross Corporation 84
Not applicableStudy completedNCT04460781
What this trial is testing

Surveillance Study to Assess the Safety of Flublok Quadrivalent (Influenza Vaccine) in Pregnant Women and Their Offspring

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 96,175
Large-scale testing (Phase 3)Study completedNCT03445468
What this trial is testing

Immunogenicity and Safety for 'IL-YANG Quadrivalent Influenza Vaccine' in Healthy Korean Children and Adolescents

Who this might be right for
Influenza, Human
Il-Yang Pharm. Co., Ltd. 379
Post-approval studies (Phase 4)Study completedNCT03969641
What this trial is testing

Safety of RIV4 Versus IIV4 in Pregnant Women

Who this might be right for
SafetyAdverse Event Following ImmunisationBirth Outcomes
Duke University 384
Large-scale testing (Phase 3)UnknownNCT02658409
What this trial is testing

A Multicenter, Double-blind, Parallel, Non-inferiority, Phase III Study

Who this might be right for
Influenza
Green Cross Corporation 1,630
Not applicableUnknownNCT05095844
What this trial is testing

National Vaccine Adverse Event Reporting Survey and Etiology

Who this might be right for
COVID-19Vaccine Adverse ReactionVaccine Reaction+10 more
Neuroganics LLC 100,000
Post-approval studies (Phase 4)UnknownNCT05298800
What this trial is testing

Combined Immunization of COVID-19 Inactivated Vaccine With QIV and PPV23

Who this might be right for
SafetyImmunogenicity, VaccineCOVID-19 Vaccines+2 more
Centers for Disease Control and Prevention, China 3,000
Post-approval studies (Phase 4)Study completedNCT02258334
What this trial is testing

Study of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose, Influenza Vaccines in Adults

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 208
Post-approval studies (Phase 4)Study completedNCT04551677
What this trial is testing

Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2020-2021 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively

Who this might be right for
Influenza ImmunizationHealthy Volunteers
Sanofi Pasteur, a Sanofi Company 90
Large-scale testing (Phase 3)Study completedNCT04024228
What this trial is testing

Study to Assess the Immune Response and the Safety Profile of a High-Dose Quadrivalent Influenza Vaccine (QIV-HD) Compared to a Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD) in Europeans Adults 60 Years of Age and Older

Who this might be right for
Influenza ImmunizationHealthy Volunteers
Sanofi Pasteur, a Sanofi Company 1,539
Testing effectiveness (Phase 2)Looking for participantsNCT06824519
What this trial is testing

Clinical Trials of Quadrivalent Influenza Vaccine

Who this might be right for
Influenza, Human
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 620
Next Page